Stock listing
BMV:AGIO Agios Pharmaceuticals, Inc. Acciones
Mexican listing (BMV) of Agios Pharmaceuticals, Inc. · home listing NASDAQ:AGIO
Follow Agios Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:AGIO
$30.55 USD -6.68 (-17.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:AGIO
- Day range
- $29.80 – $33.00 USDOct 30, 2026
- Volume
- 3.09M sharesOct 30, 2026
- Market cap
- $1.82B USDAt the close on Oct 30, 2026 · price × 59.70M shares outstanding
- 52-week range
- $22.24 – $46.00 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $37.33M USDMedian day 954,692 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:AGIO · Home | $30.55 USD | -6.68 (-17.9%) | 3,094,260 | $31.43 | $33.00 | $29.80 | $37.23 | Close on Oct 30, 2026 |
| LSE:0HB0 | $37.56 USD | +0.38 (+1.0%) | 232 | $37.35 | $37.56 | $36.50 | $37.18 | Close on Oct 27, 2026 |
| Frankfurt:8AP | €32.80 EUR | +0.40 (+1.2%) | — | €32.80 | €32.80 | €32.80 | €32.40 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:AGIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $30.55 | -6.68 | -17.9% | $31.43 | $33.00 | $29.80 | 3,094,260 | |
| $37.23 | -0.89 | -2.3% | $38.23 | $38.49 | $36.79 | 851,005 | |
| $38.12 | +0.09 | +0.2% | $37.46 | $38.44 | $36.86 | 1,201,320 | |
| $38.03 | +1.18 | +3.2% | $36.59 | $38.07 | $36.30 | 738,982 | |
| $36.85 | -0.15 | -0.4% | $37.32 | $38.13 | $36.63 | 838,530 | |
| $37.00 | -0.19 | -0.5% | $36.93 | $37.32 | $36.10 | 920,047 | |
| $37.19 | +0.01 | 0.0% | $37.22 | $37.74 | $36.35 | 931,100 | |
| $37.18 | +0.54 | +1.5% | $36.62 | $37.59 | $36.46 | 849,792 | |
| $36.64 | +1.74 | +5.0% | $35.06 | $37.00 | $35.02 | 1,518,758 | |
| $34.90 | +3.58 | +11.4% | $31.61 | $35.03 | $31.61 | 1,972,930 | |
| $31.32 | -1.00 | -3.1% | $32.35 | $32.52 | $31.16 | 952,684 | |
| $32.32 | +1.35 | +4.4% | $31.70 | $32.84 | $31.35 | 2,048,391 | |
| $30.97 | +0.76 | +2.5% | $30.07 | $31.11 | $29.67 | 930,895 | |
| $30.21 | -0.61 | -2.0% | $30.60 | $30.99 | $30.10 | 1,168,600 | |
| $30.82 | -0.99 | -3.1% | $31.84 | $32.22 | $30.69 | 647,800 | |
| $31.81 | -0.11 | -0.3% | $31.85 | $32.15 | $31.52 | 835,700 | |
| $31.92 | +0.13 | +0.4% | $31.46 | $32.32 | $31.16 | 2,078,600 | |
| $31.79 | +0.07 | +0.2% | $31.37 | $32.27 | $31.07 | 1,673,100 | |
| $31.72 | +0.47 | +1.5% | $31.49 | $32.03 | $30.79 | 1,278,300 | |
| $31.25 | -0.55 | -1.7% | $31.65 | $31.76 | $30.78 | 808,700 | |
| $31.80 | -0.68 | -2.1% | $32.82 | $32.82 | $31.65 | 569,900 | |
| $32.48 | -0.77 | -2.3% | $33.25 | $33.73 | $32.42 | 1,703,700 | |
| $33.25 | -0.05 | -0.2% | $33.67 | $34.06 | $33.20 | 1,548,500 | |
| $33.30 | -0.12 | -0.4% | $33.21 | $33.55 | $32.70 | 416,400 | |
| $33.42 | +0.84 | +2.6% | $32.53 | $34.12 | $32.35 | 1,347,700 | |
| $32.58 | -0.32 | -1.0% | $32.93 | $33.33 | $32.54 | 996,500 | |
| $32.90 | -1.29 | -3.8% | $34.02 | $34.13 | $31.37 | 1,635,100 | |
| $34.19 | -0.78 | -2.2% | $34.85 | $35.09 | $34.09 | 752,500 | |
| $34.97 | +1.02 | +3.0% | $34.19 | $35.36 | $33.88 | 1,170,400 | |
| $33.95 | +0.88 | +2.7% | $33.70 | $34.14 | $33.30 | 884,500 | |
| $33.07 | -0.54 | -1.6% | $33.29 | $33.40 | $32.77 | 1,566,200 | |
| $33.61 | +0.66 | +2.0% | $33.42 | $34.30 | $33.19 | 956,700 | |
| $32.95 | +0.14 | +0.4% | $32.89 | $33.75 | $32.74 | 863,500 | |
| $32.81 | -0.41 | -1.2% | $33.23 | $33.48 | $32.22 | 1,354,000 | |
| $33.22 | -0.38 | -1.1% | $33.83 | $34.36 | $32.89 | 794,500 | |
| $33.60 | -0.04 | -0.1% | $33.94 | $34.28 | $33.32 | 750,200 | |
| $33.64 | -0.99 | -2.9% | $34.26 | $35.28 | $33.21 | 720,200 | |
| $34.63 | +1.08 | +3.2% | $33.14 | $35.38 | $33.14 | 1,024,600 | |
| $33.55 | +0.45 | +1.4% | $32.53 | $33.93 | $32.23 | 816,400 | |
| $33.10 | -0.03 | -0.1% | $33.13 | $33.50 | $32.92 | 480,200 | |
| $33.13 | -1.00 | -2.9% | $34.28 | $34.39 | $32.95 | 516,000 | |
| $34.13 | -0.08 | -0.2% | $34.49 | $34.93 | $33.54 | 771,700 | |
| $34.21 | +0.53 | +1.6% | $33.60 | $34.34 | $33.21 | 926,800 | |
| $33.68 | +0.36 | +1.1% | $33.09 | $33.87 | $32.93 | 1,109,600 | |
| $33.32 | -0.96 | -2.8% | $33.94 | $34.36 | $33.27 | 519,700 | |
| $34.28 | +0.29 | +0.9% | $33.94 | $34.81 | $33.61 | 1,001,400 | |
| $33.99 | +0.09 | +0.3% | $33.84 | $34.43 | $33.24 | 812,000 | |
| $33.90 | +1.26 | +3.9% | $32.85 | $34.26 | $32.84 | 742,188 | |
| $32.64 | -0.45 | -1.4% | $33.25 | $33.25 | $32.61 | 635,734 | |
| $33.09 | -0.54 | -1.6% | $33.62 | $34.09 | $32.95 | 577,600 | |
| $33.63 | -1.49 | -4.2% | $34.64 | $35.09 | $33.61 | 697,500 | |
| $35.12 | +0.72 | +2.1% | $35.40 | $35.98 | $34.57 | 1,690,400 | |
| $34.40 | +0.77 | +2.3% | $33.53 | $34.83 | $33.46 | 1,187,800 | |
| $33.63 | +0.07 | +0.2% | $33.66 | $33.99 | $33.22 | 969,200 | |
| $33.56 | +0.09 | +0.3% | $33.10 | $33.81 | $32.48 | 1,124,500 | |
| $33.47 | -0.74 | -2.2% | $34.35 | $34.65 | $33.31 | 939,100 | |
| $34.21 | +1.52 | +4.6% | $32.74 | $34.31 | $32.33 | 1,223,100 | |
| $32.69 | +0.10 | +0.3% | $33.05 | $33.61 | $32.22 | 938,700 | |
| $32.59 | +0.32 | +1.0% | $31.87 | $33.10 | $31.71 | 1,071,400 | |
| $32.27 | +0.32 | +1.0% | $32.32 | $32.61 | $31.55 | 1,399,700 | |
| $31.95 | +0.23 | +0.7% | $31.44 | $32.57 | $31.44 | 1,188,200 | |
| $31.72 | +0.12 | +0.4% | $31.99 | $32.30 | $31.29 | 915,600 | |
| $31.60 | +1.06 | +3.5% | $31.04 | $31.76 | $30.23 | 1,072,500 | |
| $30.54 | +0.52 | +1.7% | $30.78 | $30.94 | $29.32 | 1,189,500 | |
| $30.02 | -2.73 | -8.3% | $33.34 | $33.34 | $29.94 | 2,102,000 | |
| $32.75 | -2.26 | -6.5% | $29.48 | $33.50 | $29.15 | 3,134,500 |
- Ticker
- BMV:AGIO
- Asset type
- Stock
- Exchange
- BMV
- Currency
- MXN
What changed lately
Latest news release · Oct 30, 2026
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA
Latest earnings call · Jul 30, 2026
Agios Pharmaceuticals (NASDAQ:AGIO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 30, 2026
Q2 2026 Earnings Presentation
Earnings · 26 slides
Calls
Upcoming
Agios Pharmaceuticals (NASDAQ:AGIO) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:00 AM ET
Register
Replays
Agios Pharmaceuticals (NASDAQ:AGIO) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 8:00 AM ET
Watch TranscriptAgios Pharmaceuticals (NASDAQ:AGIO) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 8:00 AM ET
Watch TranscriptAgios Pharmaceuticals (NASDAQ:AGIO) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA
Oct 30, 2026
Closed $30.55 (-17.9%) on Oct 30, 2026
Agios to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5 at 8: 00 a.m. ET
Oct 8, 2026
Closed $31.92 (+0.4%) on Oct 8, 2026
Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
Jul 30, 2026
Closed $32.75 (-6.5%) on Jul 30, 2026
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
Jul 21, 2026
Closed $37.36 (-6.7%) on Jul 21, 2026
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
Jul 7, 2026
Closed $44.01 (+17.7%) on Jul 7, 2026
Agios to Host Second Quarter 2026 Financial Results Conference Call and Webcast on July 30 at 8: 00 a.m. ET
Jun 29, 2026
Closed $38.04 (+0.4%) on Jun 29, 2026
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
Jun 13, 2026
Closed $31.82 (+8.0%) on Jun 15, 2026
Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib
Jun 1, 2026
Closed $28.00 (-4.8%) on Jun 1, 2026
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
May 29, 2026
Closed $29.40 (-3.4%) on May 29, 2026
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 22, 2026
Closed $28.14 (-2.3%) on May 22, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 26 slides · Jul 30, 2026
Technical Presentation (June 2026)
Technical · 18 slides · June 2026
EHA 2026 Congress
Conference · 24 slides · June 2026
Q1 2026 Earnings Presentation
Earnings · 25 slides · Apr 29, 2026
Agios Pharmaceuticals, Inc. on 6ix
- News releases
- 24 in the last 12 months · 218 in all · newest Oct 30, 2026 · oldest 2019
- Calls
- 26 calls with a replay · 26 with a transcript · latest Jul 30, 2026
- Decks
- 37 decks · latest Jul 30, 2026
Where Agios Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:AGIO · Home listing | NASDAQ | United States | USD |
| Lang & Schwarz:A1W2RM | Lang & Schwarz | Germany | EUR |
| LS Exchange:A1W2RM | LS Exchange | Germany | EUR |
| gettex:8AP | gettex | Germany | EUR |
| LSE:0HB0 | LSE | United Kingdom | USD |
| BMV:AGIO · This page | BMV | Mexico | MXN |
| Tradegate:8AP | Tradegate | Germany | EUR |
| BOATS:AGIO | BOATS | United States | USD |
| BIVA:AGIO | BIVA | Mexico | MXN |
| BX Swiss:8AP | BX Swiss | Switzerland | CHF |
| Dusseldorf:8AP | Dusseldorf | Germany | EUR |
| Frankfurt:8AP | Frankfurt | Germany | EUR |
| Munich:8AP | Munich | Germany | EUR |
| Stuttgart:8AP | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Agios Pharmaceuticals, Inc.